Literature DB >> 15033809

Inhibition of CDKs: a strategy for preventing kainic acid-induced apoptosis in neurons.

E Verdaguer1, Elvira G Jordà, Alessandra Stranges, Anna M Canudas, Andrés Jiménez, Francesc X Sureda, Mercè Pallas, Antoni Camins.   

Abstract

Stimulation of ionotropic glutamate receptors are implicated in neurodegenerative diseases such as Alzheimer's and Parkinson's diseases. Recently this has been demonstrated in the expression of cell cycle proteins in vulnerable neurons in Alzheimer's disease. Thus, the aim of the present study was to evaluate the expression of cell cycle proteins in cerebellar granule cells after stimulation of AMPA/KA receptors and likewise to study the neuroprotective effects of CDK inhibitors. Our results demonstrated that after a treatment with CDK inhibitors, a significant decrease in apoptotic nuclei induced by kainic acid was found in the presence of flavopiridol and 3-ATA. We concluded that CDK activation is involved, at least, in part, in the pro-apoptotic effects of kainic acid.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15033809     DOI: 10.1196/annals.1299.122

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

Review 1.  Cell cycle activation and spinal cord injury.

Authors:  Junfang Wu; Bogdan A Stoica; Alan I Faden
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

Review 2.  Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of central nervous system diseases.

Authors:  Da-Zhi Liu; Bradley P Ander; Frank R Sharp
Journal:  Neurobiol Dis       Date:  2009-11-24       Impact factor: 5.996

3.  Family history of melanoma and Parkinson disease risk.

Authors:  X Gao; K C Simon; J Han; M A Schwarzschild; A Ascherio
Journal:  Neurology       Date:  2009-10-20       Impact factor: 9.910

Review 4.  Cancer and neurodegeneration: between the devil and the deep blue sea.

Authors:  Hélène Plun-Favreau; Patrick A Lewis; John Hardy; L Miguel Martins; Nicholas W Wood
Journal:  PLoS Genet       Date:  2010-12-23       Impact factor: 5.917

5.  Mitosis-specific phosphorylation of amyloid precursor protein at threonine 668 leads to its altered processing and association with centrosomes.

Authors:  Monique Judge; Lisa Hornbeck; Huntington Potter; Jaya Padmanabhan
Journal:  Mol Neurodegener       Date:  2011-11-23       Impact factor: 14.195

Review 6.  Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of aberrant cell cycle diseases: an update.

Authors:  Da-Zhi Liu; Bradley P Ander
Journal:  ScientificWorldJournal       Date:  2012-04-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.